Sunrise Health Services | |
3540 S 43rd St, Milwaukee, Wisconsin 53220 | |
(414) 541-1000 | |
Name | Sunrise Health Services |
---|---|
Location | 3540 S 43rd St, Milwaukee, Wisconsin |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 85 |
Occupancy Rate | 58.47% |
Medicare ID (CCN) | 525493 |
Legal Business Name | Nsh Sunrise Llc |
Ownership Type | For Profit - Corporation |
NPI Number | 1053618470 |
Address | 3540 S 43rd St, Milwaukee, WI 53220 |
Phone Number | 414-541-1000 |
News Archive
The American Physical Society (APS), the nation's largest organization of physicists, takes special note of President Obama's speech last night that increasing scientific research and innovation and improving education are crucial to our nation's long-term economic growth.
KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced enrollment of the first patients in a Phase 2 study of KAI-4169, a novel pharmaceutical agent being tested for the treatment of secondary hyperparathyroidism (SHPT), which is a frequent and serious complication of end-stage renal disease (ESRD).
Beta-blocker therapy does not reduce the risk for cardiovascular events in patients with or without coronary artery disease, researchers say.
SafeBridge Consultants, Inc., a division of Trinity Consultants, Inc., Dallas, TX, with offices in Mountain View, CA, New York, NY, and Liverpool, UK, announces the availability of computational predictive toxicology services to the biopharmaceutical and chemical industry.
› Verified 4 days ago
NPI Number | 1205135894 |
Address | 3540 S 43rd St, Milwaukee, WI 53220 |
Phone Number | 414-541-1000 |
News Archive
The American Physical Society (APS), the nation's largest organization of physicists, takes special note of President Obama's speech last night that increasing scientific research and innovation and improving education are crucial to our nation's long-term economic growth.
KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced enrollment of the first patients in a Phase 2 study of KAI-4169, a novel pharmaceutical agent being tested for the treatment of secondary hyperparathyroidism (SHPT), which is a frequent and serious complication of end-stage renal disease (ESRD).
Beta-blocker therapy does not reduce the risk for cardiovascular events in patients with or without coronary artery disease, researchers say.
SafeBridge Consultants, Inc., a division of Trinity Consultants, Inc., Dallas, TX, with offices in Mountain View, CA, New York, NY, and Liverpool, UK, announces the availability of computational predictive toxicology services to the biopharmaceutical and chemical industry.
› Verified 4 days ago
NPI Number | 1346639143 |
Organization Name | FMG SOUTH 43RD STREET WISCONSIN LLC |
Doing Business As | SUNRISE CARE CENTER |
Address | 3540 S 43rd St, Milwaukee, WI 53220 |
Phone Number | 414-541-1000 |
News Archive
The American Physical Society (APS), the nation's largest organization of physicists, takes special note of President Obama's speech last night that increasing scientific research and innovation and improving education are crucial to our nation's long-term economic growth.
KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced enrollment of the first patients in a Phase 2 study of KAI-4169, a novel pharmaceutical agent being tested for the treatment of secondary hyperparathyroidism (SHPT), which is a frequent and serious complication of end-stage renal disease (ESRD).
Beta-blocker therapy does not reduce the risk for cardiovascular events in patients with or without coronary artery disease, researchers say.
SafeBridge Consultants, Inc., a division of Trinity Consultants, Inc., Dallas, TX, with offices in Mountain View, CA, New York, NY, and Liverpool, UK, announces the availability of computational predictive toxicology services to the biopharmaceutical and chemical industry.
› Verified 4 days ago
NPI Number | 1487172276 |
Organization Name | NSH SUNRISE LLC |
Address | 3540 S 43rd St, Milwaukee, WI 53220 |
Phone Number | 414-541-1000 |
News Archive
The American Physical Society (APS), the nation's largest organization of physicists, takes special note of President Obama's speech last night that increasing scientific research and innovation and improving education are crucial to our nation's long-term economic growth.
KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced enrollment of the first patients in a Phase 2 study of KAI-4169, a novel pharmaceutical agent being tested for the treatment of secondary hyperparathyroidism (SHPT), which is a frequent and serious complication of end-stage renal disease (ESRD).
Beta-blocker therapy does not reduce the risk for cardiovascular events in patients with or without coronary artery disease, researchers say.
SafeBridge Consultants, Inc., a division of Trinity Consultants, Inc., Dallas, TX, with offices in Mountain View, CA, New York, NY, and Liverpool, UK, announces the availability of computational predictive toxicology services to the biopharmaceutical and chemical industry.
› Verified 4 days ago
NPI Number | 1659669349 |
Address | 3540 S 43rd St, Milwaukee, WI 53220 |
Phone Number | 414-541-1000 |
News Archive
The American Physical Society (APS), the nation's largest organization of physicists, takes special note of President Obama's speech last night that increasing scientific research and innovation and improving education are crucial to our nation's long-term economic growth.
KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced enrollment of the first patients in a Phase 2 study of KAI-4169, a novel pharmaceutical agent being tested for the treatment of secondary hyperparathyroidism (SHPT), which is a frequent and serious complication of end-stage renal disease (ESRD).
Beta-blocker therapy does not reduce the risk for cardiovascular events in patients with or without coronary artery disease, researchers say.
SafeBridge Consultants, Inc., a division of Trinity Consultants, Inc., Dallas, TX, with offices in Mountain View, CA, New York, NY, and Liverpool, UK, announces the availability of computational predictive toxicology services to the biopharmaceutical and chemical industry.
› Verified 4 days ago
NPI Number | 1679732572 |
Address | 3540 S 43rd St, Milwaukee, WI 53220 |
Phone Number | 414-328-2104 |
News Archive
The American Physical Society (APS), the nation's largest organization of physicists, takes special note of President Obama's speech last night that increasing scientific research and innovation and improving education are crucial to our nation's long-term economic growth.
KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced enrollment of the first patients in a Phase 2 study of KAI-4169, a novel pharmaceutical agent being tested for the treatment of secondary hyperparathyroidism (SHPT), which is a frequent and serious complication of end-stage renal disease (ESRD).
Beta-blocker therapy does not reduce the risk for cardiovascular events in patients with or without coronary artery disease, researchers say.
SafeBridge Consultants, Inc., a division of Trinity Consultants, Inc., Dallas, TX, with offices in Mountain View, CA, New York, NY, and Liverpool, UK, announces the availability of computational predictive toxicology services to the biopharmaceutical and chemical industry.
› Verified 4 days ago
NPI Number | 1942334883 |
Organization Name | EHF SUNRISE OP, LLC |
Doing Business As | SUNRISE CARE CENTER |
Address | 3540 S 43rd St, Milwaukee, WI 53220 |
Phone Number | 414-541-1000 |
News Archive
The American Physical Society (APS), the nation's largest organization of physicists, takes special note of President Obama's speech last night that increasing scientific research and innovation and improving education are crucial to our nation's long-term economic growth.
KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced enrollment of the first patients in a Phase 2 study of KAI-4169, a novel pharmaceutical agent being tested for the treatment of secondary hyperparathyroidism (SHPT), which is a frequent and serious complication of end-stage renal disease (ESRD).
Beta-blocker therapy does not reduce the risk for cardiovascular events in patients with or without coronary artery disease, researchers say.
SafeBridge Consultants, Inc., a division of Trinity Consultants, Inc., Dallas, TX, with offices in Mountain View, CA, New York, NY, and Liverpool, UK, announces the availability of computational predictive toxicology services to the biopharmaceutical and chemical industry.
› Verified 4 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
The American Physical Society (APS), the nation's largest organization of physicists, takes special note of President Obama's speech last night that increasing scientific research and innovation and improving education are crucial to our nation's long-term economic growth.
KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced enrollment of the first patients in a Phase 2 study of KAI-4169, a novel pharmaceutical agent being tested for the treatment of secondary hyperparathyroidism (SHPT), which is a frequent and serious complication of end-stage renal disease (ESRD).
Beta-blocker therapy does not reduce the risk for cardiovascular events in patients with or without coronary artery disease, researchers say.
SafeBridge Consultants, Inc., a division of Trinity Consultants, Inc., Dallas, TX, with offices in Mountain View, CA, New York, NY, and Liverpool, UK, announces the availability of computational predictive toxicology services to the biopharmaceutical and chemical industry.
› Verified 4 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 1 |
Total Amount of Fines in Dollars | $90305 |
Number of Payment Denials | 1 |
Total Number of Penalties | 2 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 16.67 | 14.46 |
Percentage of long-stay residents who lose too much weight | 13.14 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 60.38 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 0 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 4.04 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 0.98 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 98.54 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 8.21 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 98.49 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 1.02 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 37.39 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 9.89 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 10.47 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 92.66 | 95.98 |
Percentage of short-stay residents who made improvements in function | 65.21 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 64.26 | 82.93 |
News Archive
The American Physical Society (APS), the nation's largest organization of physicists, takes special note of President Obama's speech last night that increasing scientific research and innovation and improving education are crucial to our nation's long-term economic growth.
KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced enrollment of the first patients in a Phase 2 study of KAI-4169, a novel pharmaceutical agent being tested for the treatment of secondary hyperparathyroidism (SHPT), which is a frequent and serious complication of end-stage renal disease (ESRD).
Beta-blocker therapy does not reduce the risk for cardiovascular events in patients with or without coronary artery disease, researchers say.
SafeBridge Consultants, Inc., a division of Trinity Consultants, Inc., Dallas, TX, with offices in Mountain View, CA, New York, NY, and Liverpool, UK, announces the availability of computational predictive toxicology services to the biopharmaceutical and chemical industry.
› Verified 4 days ago
Eastcastle Pl Bradford Ter Conv Ctr Location: 2505 E Bradford Ave, Milwaukee, Wisconsin 53211 Phone: (414) 963-6151 | |
Jewish Home And Care Center Location: 1414 N Prospect Ave, Milwaukee, Wisconsin 53202 Phone: (414) 276-2627 | |
Villa At Bradley Estates (the) Location: 6735 W Bradley Rd, Milwaukee, Wisconsin 53223 Phone: (414) 354-3300 | |
Maple Ridge Health Services Location: 2730 W Ramsey Ave, Milwaukee, Wisconsin 53221 Phone: (414) 282-2600 | |